Share Twitter LinkedIn Facebook Email Angela Fleischman MD PhD UC Irvine discusses Distinguishing Between Clonal Disorder & a Germ-Line Mutation Clonal disorder is a hematologic malignancy; risk of Myelofibrosis at MOASCs Spotlight On Hematology in Huntington Beach 2018.
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read